UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease

Neurobiology of disease, 2006-05, Vol.22 (2), p.233-241

2006

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Huntington’s Disease in the United States Medicare and Medicaid Populations

Neuroepidemiology, 2022-08, Vol.56 (3), p.192-200

2022

Link zum Volltext

Verfügbarkeit prüfen

Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons

Epilepsy research, 2009-01, Vol.83 (1), p.66-72

2009

Link zum Volltext

Verfügbarkeit prüfen

Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner

The Journal of neuroscience, 2008-10, Vol.28 (42), p.10720-10733

2008

Link zum Volltext

Verfügbarkeit prüfen

Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads

Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (10), p.3158-3160

2010

Link zum Volltext

Verfügbarkeit prüfen

Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models

Human molecular genetics, 2007-06, Vol.16 (11), p.1293-1306

2007

Link zum Volltext

Verfügbarkeit prüfen

Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States

Journal of medical economics, 2021-01, Vol.24 (1), p.1327-1336

2021

Link zum Volltext

Verfügbarkeit prüfen

Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs

Journal of Huntington's disease, 2016-12, Vol.5 (4), p.395

2016

Link zum Volltext

Verfügbarkeit prüfen

Stewarding Hope: The Evolving Landscape of Huntington's Disease Science Communications

Journal of Huntington's disease, 2017-01, Vol.6 (1), p.33

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology

Brain research. Molecular brain research., 2003-11, Vol.119 (1), p.28-36

2003

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of tryptophan hydroxylase activity and decreased 5‐HT1A receptor binding in a mouse model of Huntington's disease

Journal of neurochemistry, 2002-09, Vol.82 (6), p.1416-1423

2002

Link zum Volltext

Verfügbarkeit prüfen

Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain

Methods in molecular biology (Clifton, N.J.), 2004, Vol.277, p.261

2004

Link zum Volltext

Verfügbarkeit prüfen

Identification of amino-terminal sequences contributing to tryptophan hydroxylase tetramer formation

Journal of molecular neuroscience, 1999-02, Vol.12 (1), p.23-34

1999

Link zum Volltext

Verfügbarkeit prüfen

Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation

Molecular and cellular neuroscience, 2003-05, Vol.23 (1), p.28-38

2003

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine hydroxylase and tryptophan hydroxylase do not form heterotetramers

Journal of molecular neuroscience, 1998-02, Vol.10 (1), p.45-51

1998

Link zum Volltext

Verfügbarkeit prüfen

A cocaine analog, 2β-propanoyl-3β-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway

Drug and alcohol dependence, 2000-12, Vol.61 (1), p.15-21

2000

Link zum Volltext

Verfügbarkeit prüfen

A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent Abeta

Current Alzheimer research, 2007-07, Vol.4 (3), p.297

2007

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of tryptophan hydroxylase activity and decreased 5‐HT 1A receptor binding in a mouse model of Huntington's disease

Journal of neurochemistry, 2002-09, Vol.82 (6), p.1416-1423

2002

Link zum Volltext

Verfügbarkeit prüfen

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Frontiers in neurology, 2021-09, Vol.12, p.712555-712555

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease

Epidemiology of Huntington’s Disease in the United States Medicare and Medicaid Populations

Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons

Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner

Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads

Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models

Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States

Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs

Stewarding Hope: The Evolving Landscape of Huntington's Disease Science Communications

Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology

Inhibition of tryptophan hydroxylase activity and decreased 5‐HT1A receptor binding in a mouse model of Huntington's disease

Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain

Identification of amino-terminal sequences contributing to tryptophan hydroxylase tetramer formation

Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation

Tyrosine hydroxylase and tryptophan hydroxylase do not form heterotetramers

A cocaine analog, 2β-propanoyl-3β-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway

A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent Abeta

Inhibition of tryptophan hydroxylase activity and decreased 5‐HT 1A receptor binding in a mouse model of Huntington's disease

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Suchergebnisse filtern